PEG-modified arginine/lysine oxidoreductase
- 专利权人:
- 发明人:
- Christian J. Hofmann,Michael Lindemann
- 申请号：
- US14021492
- 公开号：
- US08759060B2
- 申请日:
- 2013.09.09
- 申请国别(地区):
- US
- 年份:
- 2014
- 代理人:
- 摘要：
- The present invention is directed to an arginine/lysine oxidoreductase modified with polyethylene glycol, a production method thereof, and methods of treating disorders responsive to a modification of amino acid levels reactive oxygen species and/or ammonium.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PEG-MODIFIED ARGININE/LYSINE OXIDOREDUCTASE
- Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
- Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
- USE OF PTERIDINE DERIVATIVES FOR THE TREATMENT OF INCREASED INTRACRANIAL PRESSURE, SECONDARY ISCHEMIA, AND DISORDERS ASSOCIATED WITH AN INCREASED LEVEL OF CYTOTOXIC REACTIVE OXYGEN SPECIES
- Promoter inducible by reactive oxygen species and vector comprising the same
